+25.5%
GSK vs AMDL
+505.2%
-479.7%
-18.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 2025-09-08 to 2026-09-08.
| Period | Portfolio | AMDL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.7% | +11.7% | -14.4% | -2.3% |
| 7D | -4.2% | +19.9% | -24.1% | -3.5% |
| 30D | -7.5% | +6.3% | -13.8% | -7.2% |
| 3M | -3.3% | -9.9% | +6.6% | -2.8% |
| 6M | -9.3% | +394.3% | -403.6% | -3.3% |
| YTD | +1.6% | +257.3% | -255.7% | +6.8% |
| 1Y | +25.5% | +508.5% | -483.1% | +33.5% |
| All | +25.5% | +505.2% | -479.7% | +33.5% |
Cumulative growth
Daily Returns
Daily percentage return beside AMDL.
Daily Out/Under-Performance
Portfolio return minus AMDL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AMDL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 2025-09-08 to 2026-09-08: compounded portfolio wealth divided by compounded AMDL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
2025-09-08 to 2026-09-08 analysis · Full analysis span regression · 6 months rolling